Data from the Gore ASSURED Clinical Study demonstrated 100 percent closure success at six months
Jun 4, 2019
CE Mark supported by data from the Gore ASSURED Clinical Study, demonstrating 100 percent closure success
Oct 2, 2019
Video
New addition to GORE® CARDIOFORM Occluder family is designed to treat larger atrial septal defects by adapting to the patient’s anatomy for a permanent and safe closure
Sep 26, 2017
Completion of follow -up paves way for REDUCE Clinical Study data submission to FDA for PFO indication
Mar 30, 2017